Vingroup (VIC) Establishes VinSurgical to Develop Surgical Robots and Smart Medical Devices

Overview

Vingroup (VIC) has established a new subsidiary, VinSurgical, with charter capital of VND 300 billion to develop surgical robots and smart medical devices. The move expands Vingroup’s academic healthcare ecosystem, which already includes the Vinmec hospital chain and VinUni university, and underscores the conglomerate’s push into high-tech R&D.

Key Facts

• Vingroup’s board approved the establishment of VinSurgical via Resolution No. 11/2026/NQ-HDQT-VINGROUP on May 13, 2026.
• VinSurgical has charter capital of VND 300 billion, with Vingroup holding a 51% stake (VND 153 billion).
• The subsidiary is headquartered at Symphony Office Building, Vinhomes Riverside, Long Bien District, Hanoi.
• VinSurgical will focus on research, development, and technology transfer for surgical robots, smart medical devices, and advanced medical support solutions.
• The establishment is part of Vingroup’s academic healthcare ecosystem, which includes Vinmec hospitals (operating since 2012, with JCI accreditation at some facilities) and VinUni university.
• Vingroup has previously deployed AI and big data in healthcare through units such as VinBrain, VinAI, and VinBigData.
• Vingroup also has other robotics-related companies: VinDynamics, VinRobotics, and VinMotion.

What Happened

On May 13, 2026, the board of directors of Vingroup (ticker: VIC) issued Resolution No. 11/2026/NQ-HDQT-VINGROUP approving the capital contribution to establish a new subsidiary, VinSurgical Joint Stock Company. The company will be headquartered at Symphony Office Building in Vinhomes Riverside, Hanoi.

VinSurgical will engage in research, development, and technology transfer for surgical robots, smart medical devices, and advanced medical support solutions. The subsidiary is part of Vingroup’s broader strategy to expand its academic healthcare ecosystem, which integrates clinical treatment, human resource training, and deep technology research. Vingroup has previously invested in AI and big data healthcare applications through VinBrain, VinAI, and VinBigData.

Market Context

VIC shares closed at VND 221,000 on May 13, 2026, down 0.45% with volume of 6.456 million shares on HOSE. The stock has been under pressure amid broader market weakness, but Vingroup’s continued investment in high-tech sectors may support long-term valuation. The establishment of VinSurgical aligns with the group’s diversification beyond real estate into technology and healthcare.

Strategic Significance

VinSurgical represents Vingroup’s deepening commitment to the academic healthcare model, combining clinical care (Vinmec), education (VinUni), and now medical device R&D. By developing surgical robots and smart devices in-house, Vingroup aims to reduce reliance on imported medical technology and capture value in Vietnam’s growing healthcare market. The move also leverages Vingroup’s existing robotics expertise from VinDynamics, VinRobotics, and VinMotion, creating potential synergies across the conglomerate.

What to Watch

• Timeline for VinSurgical’s first product launch or clinical trials.
• Potential partnerships with international medical device companies or research institutions.
• Integration of VinSurgical’s technology into Vinmec hospitals and other healthcare providers.
• Vingroup’s future capital allocation to VinSurgical and other high-tech subsidiaries.
• Regulatory approvals for surgical robots and medical devices in Vietnam.